Timber Hill’s AbbVie ABBV Stock Holding History

Timber Hill’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-109,100	Closed	-$7.11M	–	917
2017 Q1	$7.11M	Sell	109,100 -134,500	-55%	-$8.46M	0.05%	260
2016 Q4	$15.3M	Buy	243,600 +169,000	+227%	+$10.3M	0.07%	219
2016 Q3	$4.71M	Sell	74,600 -61,500	-45%	-$3.98M	0.02%	505
2016 Q2	$8.43M	Buy	136,100 +50,900	+60%	+$3.1M	0.04%	376
2016 Q1	$4.87M	Sell	85,200 -26,600	-24%	-$1.48M	0.02%	530
2015 Q4	$6.62M	Sell	111,800 -414,600	-79%	-$23.9M	0.03%	445
2015 Q3	$28.6M	Sell	526,400 -56,100	-10%	-$3.65M	0.12%	149
2015 Q2	$39.1M	Buy	582,500 +189,200	+48%	+$12.4M	0.18%	90
2015 Q1	$23M	Buy	393,300 +180,650	+85%	+$10.9M	0.1%	171
2014 Q4	$13.9M	Buy	212,650 +92,150	+76%	+$5.81M	0.06%	261
2014 Q3	$6.96M	Sell	120,500 -19,600	-14%	-$1.09M	0.03%	471
2014 Q2	$7.91M	Buy	+140,100	New	+$7.35M	0.04%	425

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Timber Hill's ABBV Position: Q2 2018 in Review

Timber Hill sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 11,232 shares — an estimated $1.06M sold.

Timber Hill first reported a position in ABBV in Q2 2013 and held it in 9 quarters. The position peaked at $4.51M in Q1 2015. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

Timber Hill reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
Timber Hill sold 11,232 AbbVie shares in Q2 2018, an estimated $1.06M.
Timber Hill first reported a position in AbbVie in Q2 2013 and held it in 9 quarters.
Timber Hill's AbbVie position peaked at $4.51M in Q1 2015.
1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.